THE DEAL, AT A GLANCE
2/4 reviewedAmbitious Bio
01What it doesCorpus maps where proteins appear in healthy human tissues to help researchers compare drug targets.Source-grounded · automated review · Explore ↗
02Who is involvedBacked by the data exhaust generated by existing clinical systems, the company worked backward from a consequential decisionFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAmbitious Bio raised $6M Seed, announced 2026-09-29From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersCorpus may help drug developers see where a target could act unintentionally in healthy tissue.Interpretation · Explore ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Ambitious Bio · Financing Record
Explore source-linked visual explanations for Ambitious Bio. Unsupported claims are withheld while source review continues.
Record 13032 · Recorded date: 2026-09-29
Explore company records →